Read more
About the author
Sergio Mota-Rolim studied Medicine at the Federal University of Rio Grande do Norte - UFRN (1998-2004), with undergraduate research in sleep, memory and anxiety. He did a M.Sc. in Neuroscience by the Federal University of São Paulo (2005-2007), working with the influence of biological rhythms in sleep and memory. He have a Ph.D. in Neuroscience by UFRN (2008-2012), investigating the epidemiological, cognitive-behavioral and neurophysiological aspects of lucid dreaming. He did a first post-doc at the Brain Institute and Onofre Lopes University Hospital (UFRN) (2013-2019), testing DMT for treatment-resistant depression. He is currently in a second post-doc working with sleep and COVID at the International COVID sleep study (ICOSS) (2020-2025).Renato Filev studied Biological Sciences - Medical Modality at the Universidade Federal de São Paulo - UNIFESP (2005-2008), with undergraduate research in alcohol, electroacupuncture and cannabinoids in rodent models. He have a Ph.D. in Neuroscience by UNIFESP (2010-2015), investigating the cannabinoids in behavioral models induced by drugs of abuse, He is currently does a post-doc study at the Department of Psychiatry in UNIFESP (2020-now), coordinating clinical trials with psychedelic and cannabinoid drugs for substance use disorder.
